Data Bridge Market Research analyses that the point-of-care testing (POCT) market which was USD 29 billion in 2021, would rocket up to USD 64.46 billion by 2029, and is expected to undergo a CAGR of 10.5% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get Your Sample Today: https://www.databridgemarketresearch.com/reports/point-care-testing-poct-market

Market Analysis and Insights

The rising incidence rate of diabetes and obesity, the point of care testing market for cardio metabolic testing is expected to surpass USD 5.3 billion by 2027. The percentage level of Docosahexaenoic acid (DHA) and eicosapentanoic acid (EPA) in red blood cell membrane is also determined by the cardiometabolic test. This also aids in the identification of new risk factors for cardiac arrest and other heart-related disorders. Point-of-care testing is defined as testing that may be done in close proximity to the patient and allows a medical choice to be taken immediately based on the results and monitoring. Point-of-care testing (POCT), also known as with-patient testing, allows doctors to assess accurate real-time, lab-quality diagnostic results in minutes rather than hours. It guarantees that patients get the most effective and efficient care possible, whenever and wherever they need it.

Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/point-care-testing-poct-market

Global Point-of-Care Testing (POCT) Market Scope

· The point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

· Lateral flow assays

· Dipsticks

· Microfluidics

· Molecular diagnostics

· Immunoassays

· Agglutination assays

· Flow-through

· Solid phase

· Biosensors

Prescription

· OTC testing

· Prescription-based testing

Application

· Cardio metabolic testing

· Infectious disease testing

· Nephrology testing

· Drug-of-Abuse (DoA) testing

· Blood glucose testing

· Pregnancy testing

· Cancer biomarker testing

· Other applications

End-user

· Hospitals

· Diagnostic centers

· Research laboratories

· Home-care settings

· Others

Distribution Channel

· Direct tender

· Retail Pharmacies

Global Point-of-Care Testing (POCT) Market Country Level Analysis

The point-of-care testing (POCT) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for point-of-care testing (POCT) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the point-of-care testing (POCT) market. The data is available for historic period 2010-2020.

The countries covered in the point-of-care testing (POCT) market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Browse The Table of Contents And List of Figures: https://www.databridgemarketresearch.com/toc/?dbmr=point-care-testing-poct-market

Major TOC of the Global Point-of-Care Testing (POCT) Market Report

Chapter One:

MARKET SEGEMENTATION

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Competitive Landscape and Global Point-of-Care Testing (POCT) Market Share Analysis

The point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point-of-care testing (POCT) market.

Some of the major players operating in the negative pressure wound therapy devices market are

· Abbott (U.S.)

· F. Hoffmann-La Roche Ltd (Switzerland)

· BD (U.S.)

· Siemens Healthcare Private Limited (Germany)

· Bio-Rad Laboratories, Inc. (U.S.)

· Danaher (U.S.)

· Sekisui Diagnostics (U.S.)

· Trinity Biotech (Ireland)

· bioMérieux (France)

· EKF Diagnostics (Germany)

· AccuBioTech Co., Ltd. (China)

· Instrumentation Laboratory (U.S.)

· Beckman Coulter, Inc. (U.S.)

· PTS Diagnostics (U.S.)

· Nova Biomedical (U.S.)

· Chembio Diagnostics, Inc. (U.S.)

· Quidel Corporation (U.S.)

· Sienco, Inc (U.S.)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market

Contact:

Data Bridge Market Research

Tel: +1-888-3895-2818

Email: Sopan.gedam@databridgeMarket research.com

Browse Related Reports@

North America Dental Lasers Market

Europe Dental Lasers market

Asia-Pacific Dental Lasers market